Literature DB >> 6201506

Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes.

D R Johnson, P Ferrieri.   

Abstract

Studies were carried out on the distribution of the Ibc protein antigenic marker in wild-type strains of group B streptococci of diverse serotypes isolated from epidemiological studies. Rabbits were immunized with group B streptococcal strain H36B, a prototype Ib strain, to produce antibody to the Ibc protein antigens. One antiserum (no. 970) contained antibody only against the trypsin-sensitive (TS) portion of the Ibc antigen. A second antiserum (no. 973), however, contained antibody to both the TS and the trypsin-resistant (TR) determinants or components of the antigen. A total of 785 wild-type strains of group B streptococci were serotyped by using antiserum 973 as well as antisera to the polysaccharide types Ia, Ib, II, III, and IV. Remarkably, 59% of all the strains tested (462 of 785) reacted positively with the Ibc antiserum, although not all carried both components of the Ibc antigen. Of the 99 Ib strains examined, 84% carried both TS and TR components. In contrast, 96% of the 202 Ic strains carried only the TR component of the Ibc antigen. Antiserum 970 failed to identify these strains. Routine typing with an antiserum which contains antibodies to only one portion of the Ibc antigen could result in significant serotype misidentification. Differentiation of group B streptococcal strains by the presence or absence of individual TS or TR components of the Ibc antigen could prove to be a useful additional epidemiological and serological marker. It is noteworthy that wild-type Ic strains carry, ordinarily, only the TR component, in contrast to the prototype Ic strain, which possesses the complete Ibc protein antigen. The possible contribution of the Ibc antigen to group B streptococcal virulence is of interest and requires further study.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201506      PMCID: PMC271105          DOI: 10.1128/jcm.19.4.506-510.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

Review 1.  The emergence of group B streptococci in infections of the newborn infant.

Authors:  B F Anthony; D M Okada
Journal:  Annu Rev Med       Date:  1977       Impact factor: 13.739

2.  Group B streptococcal infections in infants. The importance of the various serotypes.

Authors:  C J Baker; F F Barrett
Journal:  JAMA       Date:  1974-11-25       Impact factor: 56.272

3.  Serological relationships of type I antigens of group B streptococci.

Authors:  H W Wilkinson; M D Moody
Journal:  J Bacteriol       Date:  1969-02       Impact factor: 3.490

Review 4.  Summary of the workshop on perinatal infections due to group B Streptococcus.

Authors: 
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

5.  Polymer-induced precipitation of antigen-antibody complexes: "precipiplex" reactions.

Authors:  J C Harrington; J W Fenton; J H Pert
Journal:  Immunochemistry       Date:  1971-05

6.  Epidemiology of group-B streptococcal carriage in pregnant women and newborn infants.

Authors:  P Ferrieri; P P Cleary; A E Seeds
Journal:  J Med Microbiol       Date:  1977-02       Impact factor: 2.472

7.  Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis).

Authors:  H W Wilkinson; R R Facklam; E C Wortham
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

8.  Type-specific antigens of group B type Ic streptococci.

Authors:  H W Wilkinson; R G Eagon
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

9.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

Authors:  R C Lancefield; M McCarty; W N Everly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

10.  New approaches for the laboratory recognition of M types of group A streptococci.

Authors:  J Rotta; R M Krause; R C Lancefield; W Everly; H Lackland
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307

View more
  53 in total

1.  Inhibition enzyme-linked immunosorbent assay for serotyping of group B streptococcal isolates.

Authors:  G Arakere; A E Flores; P Ferrieri; C E Frasch
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

2.  Rapid pulsed-field gel electrophoresis method for group B streptococcus isolates.

Authors:  J A Benson; P Ferrieri
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.

Authors:  C Gravekamp; D L Kasper; L C Paoletti; L C Madoff
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  High expression of a C protein beta antigen gene among invasive strains from certain clonally related groups of type Ia and Ib group B streptococci.

Authors:  Noriyuki Nagano; Yukiko Nagano; Fumiaki Taguchi
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

5.  Influence of serotype of group B streptococci on C3 degradation.

Authors:  J R Campbell; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

6.  Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.

Authors:  N R Payne; N F Concepcion; B F Anthony
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

7.  Restriction endonuclease analysis of human and bovine group B streptococci for epidemiologic study.

Authors:  D W Denning; C J Baker; N J Troup; L S Tompkins
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

8.  Identification of non-immunoglobulin A-Fc-binding forms and low-molecular-weight secreted forms of the group B streptococcal beta antigen.

Authors:  L J Brady; M D Boyle
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

9.  Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.

Authors:  Ravin Seepersaud; Sean B Hanniffy; Peter Mayne; Phil Sizer; Richard Le Page; Jerry M Wells
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

10.  Identification of Group B Streptococcus Capsule Type by Use of a Dual Phenotypic/Genotypic Assay.

Authors:  Areej Alhhazmi; Armaan Pandey; Gregory J Tyrrell
Journal:  J Clin Microbiol       Date:  2017-06-14       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.